Africa: New Development to Develop Medicines in Africa to Fight Malaria and Tuberculosis



[ad_1]


Photo: Michael Hammond / UCT

Professor Kelly Chibale, Founder and Director of the First Integrated Center for Drug Discovery and Development in Africa, H3D at the University of Cape Town.

Cape Town – In an effort to find African solutions to African challenges, researchers across the continent are receiving grants to find new drugs for malaria, tuberculosis and neglected tropical diseases.

announced that its Drug Discovery and Development Center (H3D) is partnering with the African Academy of Sciences (AAS), the Bill & Melinda Gates Foundation and Medicines for Malaria Venture for invite researchers to submit grant proposals "Innovation led by Africans in drug discovery has historically been hampered by a number of factors, including, but not limited to, drug abuse." lack of a critical mbad of competent scientists and limited access to infrastructure. "said Professor Kelly Chibale, head of the H3D Center

" It is therefore essential to find solutions that strengthen local capacity while doing the work, which is what this new program does. "

He added that the partners would actively seek to identify and fund talented African scientists:" This will result in an increase effective number of African scientists active in drug discovery. The university said the center will provide opportunities for partners elsewhere on the continent to join drug discovery projects against malaria and tuberculosis as full members of the project. "H3D will also provide beneficiaries with the opportunity to use its infrastructure, technology platforms and expertise to fill gaps in their own environment," the university added. "Successful applicants will also be able to tap into H3D and the scientific exchange programs of the pharmaceutical industry, allowing them to gain valuable additional skills."

AAS, which runs an initiative called "Grand Challenges Africa" ​​"This opportunity is expected to create a network of drug discovery and development scientists who will initiate, develop, share, evaluate, and disseminate the best approaches and practices in the world. within the research community in Africa, "said the director. Moses Alobo, of Africa, GC,

Africa represents 17% of the world's population, but it carries a disproportionate share of 25% of the global burden of disease. Sub-Saharan Africa accounts for 90% of all malaria cases worldwide.

[ad_2]
Source link